As I predicted, Judge Stein did issue this afternoon a preliminary injunction barring further Apotex sales of its generic version of the anti-coagulant drug Plavix. However, the Judge denied Bristol Myers motion for an order requiring a recall of the generic Plavix pills that already have been distributed. (Sanofi-Aventis v. Apotex, Inc., Civil Action No. 02-CV-2255 (SHS) (S.D.N.Y.) The Judge's order can be immediately appealed to the U.S. Court of Appeals for the Second Circuit. Absent a successful appeal, the injunction will remain in force until the end of the patent dispute. The trial is set for January 2007.
CBS Marketwatch had reported a significant drop in brand name Plavix sales preceding the issuance of this order. As I previously mused, the Court's order is similar to closing the barn door after the horse is gone as massive quantities of the generic Plavix are now on the market.
No comments:
Post a Comment